Concise, science-checked coverage of skincare ingredient regulation, peer-reviewed research, and industry releases — paraphrased in our own words and credited at the source.
The Wire is editorial. We do not aggregate, republish, or accept payment for coverage. Every story is paraphrased and credited to its original publication. Read the editorial principles.
Spate's 2026 Ingredient Trends Report, released with the NYSCC, puts PDRN (+322%), centella (+147%) and beta-glucan (+740%) at the top of consumer demand. We read the same ranking through the evidence — where demand and proof agree, and where they part ways.
Filed from Skin Stacker Desk · July 18, 2026
Beta-glucan, PDRN, exosomes, ectoin, NAD+ and postbiotics are on every 2026 trend deck. Ranked by what the human evidence actually supports — from the safe add (beta-glucan) to the one to be most careful with (standalone exosomes), with an honest note on why topical NAD+ is really an ingestible question.
Filed from Skin Stacker Desk · July 18, 2026
Late-breaking data from the American Academy of Dermatology meeting points to new prescription options for atopic dermatitis, psoriasis, and chronic hand eczema. The conditions most often misdiagnosed as "sensitive skin" now have meaningful treatment options.
Filed from Dermatology Times · May 2026 issue
BASF debuted NeoHelix Regenerate and SkinNexus Collag3n at in-cosmetics Global in Paris. The first is a precision peptide designed to dock with damaged collagen; the second is a bio-identical Collagen III fragment produced by yeast fermentation. What's actually new and what to keep in proportion.
Filed from Cosmetics & Toiletries · April 10, 2026
A 21-person rater-blinded study published in MDPI Cosmetics tested a new retinol formulation against photoageing over 180 days. The headline says it works. The more useful finding is hidden in the protocol — structured irritation management — not in the molecule.
Filed from MDPI Cosmetics · April 16, 2026
Reporting from in-cosmetics Global 2026 shows the industry is dropping vague "anti-ageing" claims in favour of longevity science. It sounds like a marketing nuance — it's actually a useful one for evaluating evidence. How to read the shift, and which hyped categories to wait out.
Filed from BeautyMatter · May 3, 2026
Regulation (EU) 2026/78 came into force May 1, banning a list of substances newly classified as carcinogenic, mutagenic, or reprotoxic. Silver, hexyl salicylate, and others are now restricted. Why this affects international products outside the EU too — and what to actually do about it.
Filed from Cosmetics & Toiletries · EU Official Journal
The FDA has proposed adding bemotrizinol — used in European, Asian, and Australian sunscreens for over 20 years — to the US sunscreen monograph. A real upgrade for UVA protection. What this means for your current SPF, and what it does not.
Filed from Environmental Working Group · May 1, 2026